The story of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in sales , its patent expiration created a flood of generic competition , significantly impacting its market share . While some businesses may try to capitalize on male sexual dysfunction, the existing